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AbstrACt
Objective Our cross-sectional study aimed at evaluating 
the diagnostic performance of Focused Assessment with 
Sonography for HIV-associated tuberculosis (FASH) to detect 
extrapulmonary tuberculosis in extremely resource-limited 
settings, with visceral leishmaniasis as a differential diagnosis 
with overlapping sonographic feature.
Design Cross-sectional study.
setting Voluntary Counselling and Testing Centre (VCT) of 
Yirol Hospital, South Sudan.
Participants From May to November 2017, 252 HIV-positive 
patients out of 624 newly admitted to VCT Centre were 
registered for antiretroviral treatment. According to the number 
of trained doctors available to practise ultrasound (US) scan, 
a sample of 100 patients were screened using the FASH 
protocol.
Interventions Following a full clinical examination, each 
patient was scanned with a portable US scanner in six different 
positions for pleural, pericardial, ascitic effusion, abdominal 
lymphadenopathy and hepatic/splenic microabscesses, 
according to the FASH protocol. A k39 antigen test for 
visceral leishmaniasis was also performed on patients with 
lymphadenopathy and/or splenomegaly. All demographic, 
clinical and HIV data, as well as FASH results and therapy 
adjustments, were recorded following the examination.
results The FASH protocol allowed the detection of 
pathological US findings suggestive of tuberculosis in 27 out 
of the 100 patients tested. Overall, FASH results supported 
tuberculosis treatment indication for 16 of 21 patients, with the 
treatment being based exclusively on FASH findings in half of 
them (8 patients). The group of FASH-positive patients had a 
significantly higher proportion of patients with CD4 count below 
0.2 x109/L (n=22, 81%) as compared with FASH-negative 
patients (n=35, 48%) (p=0.003). Moreover, 48% (n=13) of 
FASH-positive patients had CD4 below 100 cells/mm3. All 
patients tested had a negative result on k39 antigen test.
Conclusion FASH was found to be a relevant diagnostic tool 
to detect signs of tuberculosis. Further research is needed to 
better define a patient profile suitable for investigation and 
also considering diagnostic accuracy.
bACkgrOunD 
In sub-Saharan Africa, the concomitant high 
burden of both HIV and tuberculosis (TB) 
has led to an increasing incidence of extrapul-
monary tuberculosis (EPTB).1 
EPTB is found more frequently in HIV-pos-
itive than in HIV-negative individuals, and the 
diagnosis is often challenging even in high-in-
come countries due to the low sensitivity and 
specificity of many available diagnostic tests 
and broad differential diagnoses.2 3
Ultrasound (US) can aid in the diag-
nosis of a variety of infectious diseases 
including EPTB, and the point-of-care ultra-
sound (POCUS) application is useful espe-
cially in resource-limited settings.4–6
Focused Assessment with Sonography for 
HIV-associated tuberculosis (FASH) is a US 
protocol aimed to detect sonographic signs 
of EPTB in patients with HIV infection.7 
The examination is focused to find effusions 
(pericardial, pleural, peritoneal), intra-ab-
dominal lymph nodes enlargement and 
microabscesses, especially in the spleen and 
strengths and limitations of this study
 ► Our study analysed the yield of the diagnostic ultra-
sound FASH (Focused Assessment with Sonography 
for HIV-associated tuberculosis) protocol in detect-
ing extrapulmonary tuberculosis  in HIV-positive 
patients from an extremely resource-limited set-
ting of rural African, without any other diagnostic 
opportunities.
 ► It is worth mentioning that South Sudan is one of 
the poorest countries in Africa, with a huge need to 
address health and to meet healthcare demand.
 ► All ultrasound examinations were performed by a 
single clinician trained in using ultrasound.
 ► This is a single-centre experience with a relatively 
small number of patients recruited.
 ► Unavailability of a definitive microbiological diagno-
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also in the liver, using six standard scanning planes in the 
abdomen and lower thorax (figure 1).7
POCUS plays a fundamental role in the diagnosis of 
different infectious conditions in contexts with limited 
resources, for example, TB, echinococcosis, amoebic 
liver abscess, intestinal schistosomiasis and visceral leish-
maniasis.4 In particular, within the context of POCUS, 
FASH protocol was demonstrated to be very useful in the 
diagnosis of TB in both HIV-positive and HIV-negative 
subjects, including children and adults.8–10
Currently, in low-income countries with limited infra-
structure and weak health systems, especially in terms 
of qualified human resources, treatment for EPTB is 
often started based exclusively on a clinical case defi-
nition.11 12 This is especially true for South Sudan, the 
youngest country in the world which has been suffering 
from years of civil war, economic downturn and famine. 
Endemic seasonal diseases such as malaria and a recent 
cholera outbreak (June 2016–February 2018)13 affect 
South Sudan’s people and further strain the already weak 
health system.
Our study aimed to (1) evaluate the diagnostic role of 
FASH for EPTB in an extremely low-resource setting as 
Yirol Hospital, South Sudan; and (2) provide information 
on visceral leishmaniasis as potential relevant differential 
diagnosis with similar sonographic features so requiring a 
different management in the same context.
MethODs
study setting and design
An observational, cross-sectional study was designed and 
implemented at the Voluntary Counselling and Testing 
Centre (VCT) of Yirol Hospital in Eastern Lakes State, 
South Sudan. Yirol Hospital serves as a referral institu-
tion for the entire Eastern Lakes State, which has an 
estimated 442 000 inhabitants.14 Yirol Hospital has no 
X-ray services available and no health facilities capable of 
X-ray exams within reasonable distance. The VCT Centre 
tests patients for HIV infection in accordance with the 
regulations and guidelines of the Ministry of Health 
of South Sudan and is authorised to provide antiretro-
viral treatment (ART) both for inpatients and outpa-
tients. Subjects referred to VCT for counselling and 
testing are quite diversified and can be categorised into 
the following: (1) admitted to hospital wards (mainly 
medical) and sent to the centre for clinical reasons by 
doctors or clinical officers; (2) sent to VCT by clinical 
officers of the outpatient department of the hospital; (3) 
spontaneously coming to the centre for testing; and (4) 
under TB treatment and also tested positive for HIV 
(in South Sudan, the treatment of TB is managed by a 
specific non-governmental organisation that is not inte-
grated in the hospital), or relatives to patients already 
enrolled.
From May to November 2017, 624 new adult patients 
accessed the VCT Centre of Yirol Hospital. Among these 
patients, 252 (40%) were positive for HIV according 
to the clinical guidelines used in South Sudan (Deter-
mine + Unigold).13 These patients were prospectively 
approached for consecutive enrolment in the study 
according with the availability of doctors trained for the 
US scan.
Following informed consent, each patient enrolled 
underwent a careful history and physical examination 
(vital signs, weight, height, and diastolic and systolic blood 
pressure, along with chest, abdomen and lymph node 
examination). Clinical staging according to the WHO 
classification (clinical guidelines of South Sudan for 
HIV) was done before US scan using clinical data only, 
following the protocol for all patients registered at VCT. 
Clinical symptoms suggestive of TB (cough, weight loss, 
haemoptysis, night sweats, fatigue) were enquired, and 
information on previous TB treatment, isoniazid preven-
tive therapy and ART history was recorded. Acid-fast 
bacilli sputum smears were carried out when necessary 
and feasible (presence of chronic cough with sputum), 
while CD4 counts were done for all patients (PIMA Anal-
yser, Alere, Jena, Germany). For patients with lymphade-
nopathy (presence of lymph nodes with at least a long 
axis diameter of more than 1.5 cm) and/or splenomegaly 
(bipolar axis >13 cm), k39 antigen test, a rapid test for 
visceral leishmaniasis, was performed (Kala-Azar test, 
Oscar Medicare, New Delhi, India).
At completion of the clinical examination, sono-
graphic scans were performed according to the FASH 
protocol.7 In brief, each patient was scanned in six 
different positions (figure 1) using a portable black-
and-white US scanner with convex (3.5 MHz) probe and 
linear (7 MHz) probe (May–October: DP-30, Mindray; 
November: M7 Premium, Mindray, Nanshan Shenzhen, 
People’s Republic of China). All US examinations were 
performed by a single clinician trained in US. At the 
end of each examination, the clinician subjectively rated 
the quality of the US views as ‘excellent’, ‘satisfactory’ or 
‘problematic’. All demographic, clinical and HIV data, 
as well as FASH results and therapy adjustments, were 
recorded following the examination.
Figure 1 FASH examination protocol: probe positions 
and findings (from Focus Assessment with Sonography for 
HIV/TB. A practical Manual, Tom Heller, 2013, TALC, with 
permission from the author). FASH, Focused Assessment 
with Sonography in HIV-associated tuberculosis. 
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According to FASH protocol, the examination was 
considered positive (FASH+) if at least one of the 
following US abnormalities was detected:
 ► Pericardial effusion (figure 2A).
 ► Periportal/para-aortic lymph nodes (>1.5 cm in diam-
eter) (figure 2B).
 ► Focal splenic lesions (figure 2C).
 ► Pleural effusion or consolidation of the lung 
(figure 2D).
 ► Ascites without alternative explanation.
 ► Focal liver lesions.
It is important to note that TB treatments in South 
Sudan are delivered by a network of centres that are not 
directly related to government hospitals nor with the 
centres providing ART. It was thus of paramount impor-
tance to develop close relationship and trust between TB 
and ART centres. The TB centre in Yirol was informed 
about the study and agreed to initiate TB treatment based 
on US and clinical results.
statistical analysis
Categorical variables were reported as absolute and rela-
tive frequencies (percentages). Χ2 test (with Fisher’s 
correction as required) was used to compare categor-
ical variables using STATA V.13. All statistical tests were 
two-tailed and statistical significance was assumed for a p 
value <0.05.
Patient and public involvement
The research question was born to respond to the health 
needs of the poorest country in the world. The idea was 
to apply a transportable, economic method, easily appli-
cable to the HIV and TB service in South Sudan. Patients 
and doctors at the Yirol Hospital were involved to better 
understand how to improve the project by sharing their 
own idea. The results of this study will be disseminated 
through a final report and other activities within the 
hospital and surrounding communities.
results
Overall, 100 patients (52% female) were enrolled in the 
study and underwent full clinical examination followed 
by a FASH US evaluation. Table 1 summarises the demo-
graphic and clinical characteristics of the whole patient 
cohort stratified by FASH results (positive vs negative). 
Abnormal US findings consistent with FASH positive 
exams were detected in 27 (27%) patients.
The FASH-positive patients group had a significantly 
higher proportion of patients with CD4 count below 0.2 
x109/L3 (n=22, 81%) as compared with FASH-negative 
patients (n=35, 48%) (p=0.003); moreover 48% (n=13) 
of FASH-positive patients had CD4 below 100 cells/mm3.
WHO HIV stage significantly differed in the two 
groups (p=0.001), with a higher proportion of stage III 
(n=17, 63%) and stage IV (n=5; 18%) in FASH-positive 
patients as compared with the negative ones. Of the 
FASH-positive patients, 93% (n=25) were ART-naïve, 
even if no statistical difference was documented with the 
comparison group (p=0.177). The proportion of patients 
accessing a previous TB treatment was significantly higher 
(p=0.003) in FASH-positives (n=7, 26%) as compared with 
patients who are FASH-negative (n=3, 4%). A borderline 
statistical difference was highlighted between positive 
and negative FASH patients with regard to pharmacolog-
ical TB prophylaxis (p=0.059), this practice being more 
frequently reported in FASH-positive patients (n=10, 
37%) than in negative ones (n=13, 18%).
FASH positivity results, according to WHO HIV stage, 
are shown in figure 3. The proportion of FASH positivity 
significantly increases with the stage as compared with 
FASH-negative group (p=0.001).
In table 2 are reported additional diagnostic results of 
the 27 patients with US pathological findings. Sputum test 
was positive in 5 of the 27 patients (18%), while all the 
patients tested for k39 had negative results. Eighty-eight 
per cent of FASH-positive patients were symptomatic, but 
clinical examination resulted negative in 74% (n=20) of 
patients for palpable lymph adenopathies, in 89% (n=24) 
Figure 2 Examples of ultrasound findings in patients with positive results on FASH examination admitted to Yirol Hospital, 
South Sudan. (A) Pericardial effusion, (B) periportal/para-aortic lymph nodes (>1.5 cm in diameter), (C) focal splenic lesions, and 
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for lung abnormalities and in 85% (n=23) for abdomen 
abnormalities.
The pathological findings documented in the 27 
FASH-positive patients are summarised in table 3. Of the 
three patients with ascites, one had an additional pleural 
effusion and one had splenic microabscesses. With regard 
to one patient with ascites as the only finding, as no other 
cause for ascites was detected (normal liver, spleen, 
Table 1 Demographic and clinical characteristics of 100 patients recruited at Yirol Hospital, South Sudan, stratified by FASH 
results
Total (N=100) FASH-positive (n=27) FASH-negative (n=73) P value
Demographic characteristics 
Gender
  Male 48 (48) 12 (44) 36 (49) 0.82
  Female 52 (52) 15 (55) 37 (51)
Age
  18–30 34 (34) 6 (22) 28 (38) 0.26
  31–40 44 (44) 12 (44) 32 (44)
  41–50 14 (14) 6 (22) 8 (11)
  >50 8 (8) 3 (11) 5 (7)
Address 
  Yirol Town 36 (36) 14 (52) 22 (30) 0.272
  Yirol East 35 (35) 8 (30) 27 (37)
  Yirol West 22 (22) 4 (15) 18 (25)
  Other 7 (7) 1 (4) 6 (8)
Setting 
  Inpatient 58 (58) 19 (70) 39 (53) 0.17
  Outpatient 42 (42) 8 (30) 34 (47)
 Clinical characteristics
Body mass index (kg/
m2) 
  Low <18 83 (89) 20 (74) 63 (86) 1
  Normal  18–25 9 (10) 2 (7) 7 (10)
  High >25 1 (1) 0 (0) 1 (1)
CD4
  0.2 x109/L 57 (57) 22 (81) 35 (48) 0.003
WHO HIV stage
  I 13 (13) 0 (0) 13 (18) 0.001
  II 30 (30) 5 (18) 24 (33)
  III 50 (50) 17 (63) 33 (45)
  IV 7 (7) 5 (18) 2 (3)
Previous antiretroviral treatment 
  Yes 3 (3) 2 (7) 1 (1) 0.177
  No 97 (97) 25 (93) 72 (99)
Previous TB treatment 
  Yes 10 (10) 7 (26) 3 (4) 0.003
  No 90 (90) 20 (74) 70 (96)
TB prophylaxis 
  Yes 23 (23) 10 (37) 13 (18) 0.059
  No 77 (77) 17 (63) 60 (82)
FASH, Focused Assessment with Sonography in HIV-associated tuberculosis; TB, tuberculosis. 
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heart and kidneys) and his CD4 count was very low (28 
cells/mm3), also in light of the presence of a clinical 
wasting syndrome, it was decided to start TB treatment.
TB treatment was initiated in 21 (21%) patients after 
complete clinical and diagnostic examination (table 4). 
Overall, FASH results supported TB treatment indication 
in 76% (n=16) of all patients started; of interest, in half 
of them (n=8), treatment was based exclusively on FASH 
findings.
Out of 27 patients with abnormal FASH results, only 
18 started TB treatment. Several reasons determined this 
clinical decision: two patients with pericardial effusion left 
the hospital before starting treatment; five were positive 
for pleural effusion or lung consolidation and were first 
treated as pneumonia with improvement; one showed a 
single focal hypoechoic lesions of the liver with an axis 
of 2 cm and was addressed to start ART treatment with a 
strict follow-up of the liver lesion; and one patient with 
abdominal lymph nodes, peritoneal and pleural-free effu-
sion and splenic hypoechoic lesions died before initiating 
TB treatment. All patients (n=13) with enlarged lymph 
nodes, splenomegaly or splenic lesions were tested for 
antibody against k39 protein and all tests were negative.
The quality of the US examination rated by the clini-
cian was ‘excellent’ in 39% (n=39) and ‘satisfactory’ in 
56% (n=56); 5% (n=5) of the exams were considered 
‘problematic’.
Figure 3 WHO HIV stage according to FASH positivity 
among the 100 enrolled patients at Yirol Hospital, South 
Sudan. FASH, Focused Assessment with Sonography in HIV-
associated tuberculosis.
Table 2 Additional diagnostic characteristics of the 27 
patients with positive results on FASH examination, admitted 
to Yirol Hospital, South Sudan
Sputum test 
  Positive 5 (18)
  Negative 13 (48)
  Not done 12 (44)
Kala-Azar test 
  Negative 13 (48)
  Not done 14 (52)
Symptoms 
  Yes 24 (89)
  No 3 (11)
CD4 (cells/mm3) 
  <100 13 (48)
  >100 to ≤200 9 (33)
  >200 5 (18)
Lymph nodes clinical examination 
  Yes 7 (26)
  No 20 (74)
Lung clinical examination 
  Positive 3 (11)
  Negative 24 (89)
Abdomen clinical examination 
  Positive 4 (15)
  Negative 23 (85)
FASH, Focused Assessment with Sonography in HIV-associated 
tuberculosis.
Table 3 Sonographic findings in 27 patients with positive 
FASH examination, admitted to Yirol Hospital, South Sudan
Pathological findings n (%)
Periportal/para-aortic lymph nodes 15 (55)
Pericardial effusion 9 (33)
Lung consolidation 8 (30)
Pleural effusion 5 (18)
Splenic focal lesions 4 (15)
Ascites 3 (11)
Ascites in the pouch of Douglas 3 (11)
Liver focal lesions 1 (4)
Ascites in the splenorenal pouch 1 (4)
Ascites in the hepatorenal pouch 
(Morison’s pouch)
0 (0)
FASH, Focused Assessment with Sonography in HIV-associated 
tuberculosis.
Table 4 Indications for TB treatment initiation in 21 patients 
among the 100 enrolled at Yirol Hospital, South Sudan
Indication for TB treatment initiation n (%)
Only FASH 8 (38.1)
Only sputum test 0 (0)
Only clinical reasons 2 (14.3)
FASH + sputum test 4 (19.0)
FASH + clinical reasons 3 (14.3)
Sputum test + clinical reasons 2 (9.5)
FASH + sputum + clinical reasons 1 (4.8)
Total FASH 16 (76.2)
Total sputum test 8 (38.1)
Total clinical reasons 5 (23.8)
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DIsCussIOn
This observational study evaluated the yield of a diag-
nostic tool (FASH) for EPTB in Eastern Lakes State (Yirol 
Hospital), South Sudan. The FASH protocol allowed the 
detection of pathological US findings suggestive of TB in 
27 out of the 100 patients tested.
The most frequent pathological findings documented 
were periportal/para-aortic lymph nodes, pericardial 
effusion and lung consolidation. FASH findings were 
more likely to be detected in patients with advanced HIV 
disease with CD4 count <200 cells/mm3, WHO stage III/
IV and low body mass index (BMI). The quality of the US 
view was mostly rated as excellent and satisfactory by the 
clinician performing the examination.
Our findings support the important role of this simple, 
inexpensive and fast technique in resource-limited setting 
as the Yirol Hospital.15–17 Moreover, we were able to iden-
tify a core group with the highest yield in FASH, repre-
sented by patients with low BMI, low CD4 and advanced 
WHO stage.
FASH can be taught rapidly to physicians with limited or 
no prior US experience.18 In high prevalence setting, the 
learning process is facilitated by the presence of patholog-
ical findings in a large proportion of HIV/TB coinfected 
patients,19–22 which is supported by our data. Moreover, 
the fact that many patients under investigation are under-
weight makes scanning easier, as abdominal volume 
interfering with scanning becomes less relevant. The 
examination takes only a few minutes and may provide 
important findings with a direct and significant impact 
on patient management.2 23 Nevertheless, an important 
operational question is related to operators who can reli-
ably use this diagnostic technique. In our single-centre 
experience, we did not succeed in motivating the local 
clinical officers of the hospital to be trained in the use of 
US. Young clinicians seemed absolutely more motivated. 
This is probably related to the poor capacity of the lower 
cadre of clinical staff in using diagnostic imaging tools 
and to the fact that the clinical officers in Yirol Hospital 
are not exclusively dedicated to the care of patients with 
HIV, and they had many concurrent competing tasks and 
activities.
Although the diagnosis of EPTB based on abnormal 
US examination is not certain, it is justified to start a TB 
treatment based on these findings considering data from 
the literature and the lack of any other diagnostic tools 
for further work-up in a rural health setting.
In the region where the study was conducted, there are 
no epidemiological data for Leishmania spp infection, but 
this infectious disease is known to be locally prevalent in 
South Sudan. According to the documents of the Ministry 
of Health of South Sudan, visceral leishmaniasis is 
endemic in four states in South Sudan, namely Upper 
Nile, Unity, Jonglei and Eastern Equatoria; 2.7 million 
people are considered to be at risk in 28 counties.24–26 For 
this reason, we also tested patients for visceral leishman-
iasis as this could be considered a potential differential 
diagnosis with overlapping imaging findings of enlarged 
lymph nodes and spleen lesions. With the sensitivity and 
specificity of the immunochromatographic strip test 
being more than 90%,27 by using the k39 antigen test 
in patients with an abnormal US result we were able to 
exclude the presence of visceral leishmaniasis.
Our study has some limitations, which include the 
relatively small number of patients, the unavailability 
of a definitive microbiological diagnosis and the lack 
of follow-up, but we believe our results remain relevant 
in light of the study setting. South Sudan is a country 
devastated by civil war, economic downturn and health 
epidemics such as cholera. As reported by previous studies 
conducted in such a deprived context with a vulnerable 
target population affected by HIV-related diseases,28 29 
healthcare organisational models, human and technical 
resources, especially the availability of diagnostic tests, 
may have relevant implications on the pathways of care 
dedicated to patients with HIV.30
There is an increasing interest in employing US in 
low-income and middle-income countries given its rela-
tively steep learning curve, ionisation radiation-free 
nature and its increasing availability at reasonable 
costs.4 17 31 Moreover, it can be portable and can operate 
with batteries, being independent from a stable elec-
tric power supply.4 US gel, the only routine supply item 
needed, can be easily produced locally, thus making US 
an attractive option in resource-limited settings.16 On the 
other hand, some concern remains about the intrinsic 
interobserver variability and the potential for diagnostic 
errors, which should moreover be investigated specifi-
cally for TB. While the conditions for a wider implemen-
tation are favourable, few studies have been performed 
in low-income countries especially in rural settings. Our 
observation adds to the available evidence indicating that 
the use of FASH for the diagnosis of TB can be useful in 
this setting.
COnClusIOns
FASH was found to be a relevant diagnostic tool to detect 
signs of EPTB, even in an extremely resource-limited 
setting such us South Sudan, where HIV and TB incidence 
is high and radiological and microbiological investigations 
are scarce. Our data contributed data to better charac-
terise a patient population with the highest yield, namely 
patients with low BMI, low CD4 and advanced WHO 
stage, while further research that considers feasibility and 
diagnostic accuracy is needed. Other interesting fields 
requiring further research include the training of health 
operators and the shifting of the procedure to the local 
staff.30
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